-
- 1800 2010
- EN
-1366x0.jpg)
News
Array
(
[0] => stdClass Object
(
[id] => 1127
[id_crawler] =>
[category_product] => NULL
[thumbnail] => ht-sk_2023/spk_can_tho/z4645891556172_9b8c31f085ca4142bd01e8c44c47da2a.jpg
[album] =>
[url_video] =>
[is_status] => 1
[is_featured] => 0
[is_form] => 1
[displayed_time] => 2023-08-29
[program] => 0
[number] => 1
[viewed] => 0
[type] =>
[type_career] =>
[level] =>
[address] =>
[address_career] =>
[expiration_time] => 0000-00-00
[created_time] => 2023-08-29 11:50:24
[updated_time] => 2024-08-15 15:50:41
[files] =>
[salary] =>
[time] =>
[created_by] => 63
[is_table_content] => 1
[language_code] => en
[slug] => gentis-participated-in-the-8th-can-tho-obstetrics-and-gynecology-conference
[title] => GENTIS participated in the 8th Can Tho Obstetrics and Gynecology Conference
[description] => GENTIS participated in the 8th Can Tho Obstetrics and Gynecology Conference, held on August 25, 2023, at Van Phat Riverside Convention Center. Over 1,000 delegates from across the country attended the conference. GENTIS was honored to provide information on male infertility testing for Dr. Mai Ba Tien Dung's article on the topic of "Updating male infertility and the role of genes".
[content] => The Can Tho Obstetrics and Gynecology Conference is an annual event of the healthcare system in the Mekong Delta region, organized by Can Tho Maternity Hospital, serving as a platform for healthcare professionals from Vietnam and around the world to exchange knowledge and experiences in the field of obstetrics and gynecology.
The Can Tho Obstetrics and Gynecology Conference attracted a significant number of obstetricians and gynecologists from both domestic and international institutions.
Attendees of the 8th Can Tho Obstetrics and Gynecology Conference included Specialist Level II Dr. Nguyen Huu Du, Director of Can Tho Maternity Hospital; Prof. Nguyen Viet Tien M.D, PhD, former Vice Minister of Health and President of the Vietnam Association of Obstetrics and Gynecology; Prof. Nguyen Thi Ngoc Phuong M.D, PhD, President of HOSREM HCMC; Assoc. Prof. Tran Danh Cuong M.D, PhD, Director of the National Hospital of Obstetrics and Gynecology and Head of the Obstetrics Department at Hanoi Medical University, along with numerous other experts from Hanoi, Hai Phong, Hue, Ho Chi Minh City, the United States, France, and Korea.
The conference was highly regarded for its organization and the quality of its scientific presentations, which showcased significant advancements in the field. The 8th Can Tho Obstetrics and Gynecology Conference featured one plenary session and eight scientific sessions, with a total of 62 research papers were presented, covering a wide range of topics such as obstetrics, gynecology, assisted reproduction, neonatology, and prenatal screening.
Notably, the conference expanded its scope to include emerging topics such as fetal medicine, menopause, natural orifice transluminal endoscopic surgery, pregnancy nutrition, and prenatal yoga, as well as international presentations. These scientific presentations were the result of extensive research and clinical experience by leading experts from major hospitals across the country and abroad.
GENTIS is honored to have provided the andrology testing data for Mai Ba Tien Dung, M.D, PhD's article on "Updates on male infertility and the role of genetics."
In the Assisted Reproductive Technology session, Mai Ba Tien Dung M.D, PhD (Head of Andrology Department at Binh Dan Hospital in HCM city), presented his research on "Updates on male infertility and the role of genetics," which was highly regarded by experts. GENTIS is proud to have provided the andrology testing data for this research.
Mai Ba Tien Dung M.D, PhD shared, according to the WHO, infertility is defined as the inability of a couple to conceive after one year of regular unprotected intercourse (for women under 35) or six months (for women aged 35 and over). Approximately 1 in 6 couples worldwide experience infertility at some point in their lives. Male infertility accounts for about 40-50% of infertility cases and affects 2.5-12% of men. In Vietnam, the infertility rate among young couples is currently 7.7%. Of these, primary infertility accounts for 3.9% and secondary infertility for 3.8% (Ministry of Health, 2019).
Chromosomal abnormalities have been linked to male infertility since the 1990s. It is estimated that 15-30% of male infertility cases are associated with chromosomal abnormalities. These abnormalities can affect sperm production, shape, and motility, as well as hormone levels and physical appearance. Additionally, chromosomal aneuploidies in sperm (such as trisomy 13, 18, 21, X, and Y) can lead to recurrent miscarriages, fetal abnormalities, and infertility in the next generation. Therefore, genetic testing is essential for diagnosing the causes of male infertility and is highly valued by healthcare professionals in the evaluation and treatment of infertile couples.
The scientific presentations delivered by the speakers at the conference were highly commended by experts.
As a pioneer in genetic analysis in Vietnam and a leading provider of solutions to improve the success rate of assisted reproduction, GENTIS offers a comprehensive range of andrology tests, including:
- AZF microdeletion test
- Sperm DNA fragmentation test
- CFTR gene mutation test
- Sperm aneuploidy test.
- …..
Through the 8th Can Tho Obstetrics and Gynecology Conference, GENTIS aims to promote its comprehensive andrology testing services to specialists in assisted reproductive technology and couples facing infertility. Once again, GENTIS would like to congratulate the organizing committee on the successful conclusion of the conference.
The 23rd Vietnam-France-Asia-Pacific Conference on Obstetrics and Gynecology (VFAP 23) was held on August 17th and 18th, 2023, at the Riverside Palace Convention Center, located at 360D Ben Van Don Street, District 4, Ho Chi Minh City. The event was co-organized by Tu Du Hospital with The Chinese University of Hong Kong & the Department of Obstetrics and Gynecology of Prince of Wales Hospital.
.jpg)
GENTIS is honored to be a Silver Sponsor of the 23rd Vietnam-France-Asia-Pacific Conference on Obstetrics and Gynecology.
The conference serves as a prestigious forum, providing an opportunity for domestic and international experts to gather and exchange experiences in diagnosis, treatment, research, and development in the field of Obstetrics and Gynecology. Notably, this year’s conference is honored to welcome professors, doctors, and experts from the Asia Pacific Congress in Maternal Fetal Medicine (APCMFM),...
Over the course of two days, on August 17th and 18th, 73 research papers were presented by scientists and experts, showcasing modern medical perspectives. The presentations focused on timely topics, sharing in-depth knowledge and the latest updates in prenatal diagnosis, antenatal care, obstetrics and gynecology, including:
- Management of gynecological cancers
- Advances in improving women's health
- Optimizing hormone therapy for menopause
- The role of hormones in obstetrics and gynecology
- Updates on non-invasive prenatal screening - Scientific basis
- Updates on non-invasive prenatal screening - Clinical applications
…
.jpg)
GENTIS's booth attracted a large number of interested customers and delegates.
As a Silver Sponsor, GENTIS is honored to have participated in this significant conference and showcased our products. This demonstrates GENTIS's ambition to become a leading testing center in Vietnam and Asia, providing a comprehensive ecosystem of tests for women and fetuses.
Through our product demonstrations at the booth, GENTIS is proud to have introduced high-quality genetic tests and received positive feedback from leading obstetricians and gynecologists nationwide:
- Prenatal genetic screening (Thrombophilia, Thalassemia), non-invasive prenatal testing (NIPT GenEva)
- Assisted reproductive technology (PGT-A, PGT-M, PGT-Max 1, FSH, ASEM test, Genratest, Karyotype);...
Many lucky customers won prizes at the GENTIS booth.
In addition, GENTIS offered a variety of fun games and lucky draws with 100% winning chances for all delegates at the booth, including bamboo cups, canvas bags, and maternity spinning wheels,... The mini-games were lively and attracted the participation of a large number of guests and delegates.
Mr. Do Manh Ha, General Director of GENTIS, shared: “We are extremely proud to be a part of such a prestigious national and regional medical event like the 23rd Vietnam-France-Asia-Pacific Conference on Obstetrics and Gynecology. This is a testament to GENTIS's commitment to improving the health and stature of Vietnamese people. GENTIS will continue to strive to research and develop genetic tests to bring the best health values to the Vietnamese community.”
GENTIS is a pioneering company in the field of genetic analysis applications in Vietnam, having been established in October 2010 by a team of specialized biotechnology scientists. Over the course of its 13 years of operation, GENTIS has proven its exceptional quality in DNA testing, non-invasive prenatal testing (NIPT), reproductive support, pediatrics, and oncology. With its accuracy, reliability, and speed, GENTIS has consistently maintained the complete trust of its partners and valued customers.
The scene of the signing ceremony for the strategic partnership between GENTIS and MIC Vietnam.
MIC Vietnam is known as a high-quality medical center, specializing in providing basic to advanced testing services, quickly and accurately. After more than 2 years of establishment and development, MIC Vietnam has always strived to bring its customers professional, modern, and clinically standardized medical services. From there, it aims to build a more proactive, comprehensive, and effective healthcare ecosystem
To elevate the quality of healthcare services for the people of Ho Chi Minh City in particular, and the populace of Vietnam in general, GENTIS and MIC Vietnam have reached a significant cooperative agreement, opening new opportunities to drive the advancement of medical tests, scientific research, as well as human resource training. Under the Cooperation Agreement, the two parties pursue a long-term partnership, providing comprehensive medical solutions, and optimally promoting and supporting the development of both sides. Simultaneously, this will create an overall synergy to address the increasingly growing healthcare needs of Vietnamese people effectively.
Representing GENTIS, the signing ceremony had the appearances of Mr. Do Manh Ha (the Chief Executive Officer of GENTIS) and Ms. Tran Thi Ha Dong (the Commercial Director of GENTIS in the Ho Chi Minh City region). On behalf of MIC Vietnam, the distinguished guests included Mr. Phung Duy Hai (the Chief Executive Officer of MIC Vietnam), Ms. Tran Kim Ngan (the Director of Operations) and Mr. Nguyen Huu Giau, (the Director of Business) accompanied by other members of the company's personnel.
Mr. Do Manh Ha (Chief Executive Officer of GENTIS) delivered a speech at the ceremony.
Speaking at the ceremony, Mr. Do Manh Ha, (Chief Executive Officer of GENTIS) stated: "I am delighted to represent GENTIS in attending this important strategic cooperation signing event. With 13 years of experience in the field of genetic analysis development, GENTIS was also the pioneering company in Vietnam to bring the latest generation of gene sequencing technology to the country. After a prolonged period of establishment and growth, GENTIS has not only focused on the Obstetrics segment, but has also expanded its expertise into other areas such as oncology, newborn screening, and assisted reproduction. We are extremely proud that GENTIS is not only the industry leader in Vietnam for genetic testing, but we are also a member of the Eurofins Group - the world's preeminent testing company. Aligned with GENTIS's mission of 'Elevating the health of the Vietnamese people', I believe that our two organizations share a common goal of empowering the people of Vietnam to achieve even greater health and vitality. This signing ceremony today will help elevate that transformative mission even further in the years to come."
Mr. Phung Duy Hai (Chief Executive Officer of MIC Vietnam) delivered a speech at the ceremony.
Mr. Phung Duy Hai (Chief Executive Officer of MIC Vietnam) stated: "MIC Vietnam's core mission is to construct a proactive healthcare ecosystem for the people. Therefore, MIC Vietnam places a strong emphasis on proactive periodic testing, and this roadmap has been designed to ensure effective healthcare. In order to provide the citizens with these proactive healthcare solutions, we always aim for services with a proactive healthcare ecosystem along with new technology solutions and collaboration with domestic and international partners. This includes importing equipment from G7 countries and aligning our practices with ISO 15189 standards. I believe that with MIC Vietnam's collaboration with GENTIS, we will further fulfill our mission, meet customer needs, and contribute to improving the quality of services particularly, and the laboratory testing in Vietnam generally.”
The handshake between GENTIS and MIC Vietnam carried profound significance and noble humanitarian value.
Undoubtedly, this collaborative plan will deliver highly advanced, premium-quality healthcare services to the Vietnamese people. This noble mission has been, and will continue to be, the guiding principle that both GENTIS and MIC Vietnam have steadfastly upheld in their unwavering commitment to the community over time. It is our fervent hope that this latest synergistic partnership between the two companies will provide an even more ideal medical service experience for our valued customers.
The prenatal class had the participation of Specialist Level 1 Dr. Hoang Dang Thong - Deputy Head of the Obstetrics Department; Ms. Bui Thi Diem - Head Midwife; Pharmacist Duong Thi Phuong - Head of Product Management (PM), representative of GENTIS company and more than 50 parents are consulting in the obstetrics department at the hospital.
In the class, the expectant mothers were able to share knowledge about pregnancy safety, common problems as well as how to handle them in each stage of pregnancy, instructions for newborn care, etc. The program with useful knowledge, received enthusiastic support from the participating parents
Especially, Pharmacist Duong Thi Phuong brought a lecture on NIPT EVa prenatal malformation screening test and newborn screening, which is the topic drawing the most interest from pregnant mothers nowadays. Those pregnant moms listened attentively as well as asked a lot of questions about the two tests above and received the answers in great detail.
The NIPT GenEva prenatal malformation screening test detects aneuploidy abnormalities on all 23 pairs of chromosomes of the baby from the mother's 10 weeks of pregnancy, to detect common-seen syndromes such as Down, Edwards, Patau, etc. Some pregnant mothers who participated in the class also shared that they had done NIPT tests for their babies and felt much more secure during pregnancy.
Newborn screening uses a blood sample from the baby's heel to check for early detection of diseases such as G6PD deficiency, congenital hypothyroidism, congenital adrenal hyperplasia, galactosemia, phenylketonuria, hemoglobin, etc. As a result, there is a timely treatment plan, preventing the conditions from worsening and becoming more difficult to manage. Neonatal screening tests help minimize treatment costs and reduce the burden on families and society.
Under the meticulous explanation of Pharmacist Phuong, parents have clearly understood the importance of testing, some parents registered for newborn screening tests for their children at the obstetrics department of the hospital.
[content_more] => [meta_title] => GENTIS accompanies with the August prenatal class of General Hospital of Bac Thang Long [meta_description] => On the morning of August 17, 2023, GENTIS collaborated with the General Hospital of Bac Thang Long to successfully organize a prenatal class in August for more than 50 pregnant mothers. Here, GENTIS provided pregnant moms with useful knowledge about NIPT [meta_keyword] => General Hospital of Bac Thang Long [thumbnail_alt] => [post_id] => 1124 [category_id] => 4 ) [4] => stdClass Object ( [id] => 1123 [id_crawler] => [category_product] => NULL [thumbnail] => ht-sk_2023/san_phu_khoa_viet_phap_150823/san-phu-khoa-viet-phap-2023-2.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 0 [displayed_time] => 2023-08-17 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2023-08-17 16:56:37 [updated_time] => 2024-08-15 15:36:38 [files] => [salary] => [time] => [created_by] => 62 [is_table_content] => 1 [language_code] => en [slug] => gentis-is-honore-to-be-the-silver-sponsor-at-the-2023-vietnam-france-obstetrics-and-gynecology-conference [title] => GENTIS is honored to be the Silver sponsor at the 2023 Vietnam-France Obstetrics and Gynecology Conference [description] => The 23rd Vietnam-France Obstetrics and Gynecology Conference was jointly organized by the National Hospital of Obstetrics and Gynecology, and the French College of Gynecology and Obstetrics (CNGOF). The event took place on August August 14-15th, 2023, utilizing the HYBRID format: with both virtual participation via the Zoom platform as well as an in-person meeting at the Lotte Hotel Conference Hall in Hanoi, located at 54 Lieu Giai, Ba Dinh district. The conference was a resounding success. GENTIS was honored to serve as a Silver Sponsor, with a booth to introduce the products and provide data to support the experts' in-depth presentations. [content] =>The 2023 Vietnam-France Obstetrics and Gynecology Conference was a highly esteemed and eagerly anticipated annual scientific event organized by the National Hospital of Obstetrics and Gynecology. The conference served as a platform for domestic and international experts to convene, share clinical and paraclinical experiences, as well as keep abreast of the latest advancements in the fields of obstetrics, gynecology, neonatology, assisted reproductive technology, fetal medicine, pharmaceuticals, and more.
Nguyen Viet Quang, M.D, M.Sc., presented a report on "The Significance of Non-Invasive Prenatal Testing (NIPT) in Multiple Pregnancy Management"
The conference program included 1 plenary session, 8 specialized thematic sessions, featuring the presentation and discussion of 55 scientific papers, as well as 4 side workshops addressing the most topical issues in the domains of obstetrics and gynecology, assisted reproductive technology, endocrinology, neonatology, pharmaceuticals, and more. The event drew the participation of thousands of professors, physicians, and experts from leading hospitals across Vietnam as well as countries with renowned healthcare systems globally.
GENTIS was proud to serve as a Silver Sponsor of the 2023 Vietnam-France Obstetrics and Gynecology Conference, and had organized numerous engaging side activities. Notably, GENTIS's exhibition booth showcasing the products had received substantial interest from the large number of attendees and delegates. Leading experts in the fields of obstetrics, gynecology, and assisted reproductive technologies had expressed high praise for GENTIS's genetic testing solutions, especially PGTest, FSH receptor gene polymorphisms, NIPT GenEva, and newborn screening, etc.
In addition to the genetic testing consultation activities, the GENTIS exhibition booth also organized a variety of games and a lucky draw program, with a 100% chance of winning prizes for the distinguished delegates and physicians in attendance… Through the introduction of the genetic testing services at the conference, GENTIS hopes to continue collaborating with esteemed physicians/ clinics/ hospitals/ IVF centers in bringing cutting-edge genetic tests closer to expectant mothers in Vietnam.
Many lucky guests received meaningful gifts from GENTIS
Particularly, GENTIS was honored to collaborate with scientific presentations delivered by leading experts in the fields of assisted reproductive technologies and pediatrics:
- "Poor Ovarian Response" by Assoc. Prof. Ho Sy Hung, PhD. (Deputy Director, National Assisted Reproductive Technology Center)
- "The Significance of Non-Invasive Prenatal Testing (NIPT) in Multiple Pregnancy Management" by Nguyen Viet Quang, M.D, M.Sc. (Director, National Assisted Reproductive Technology Center - National Hospital of Obstetrics and Gynecology)
- "Newborn Screening for Hemoglobin Disorders" by Tran Thi Chi Mai, PhD. (Head of Biochemistry Department, National Children's Hospital - Hanoi Medical University)
Assoc. Prof. Ho Sy Hung, PhD. (Deputy Director, National Assisted Reproductive Technology Center) presented the scientific report "Poor Ovarian Response and FSH Receptor Gene Polymorphisms"
The three specialized and in-depth presentations delivered by leading experts clearly affirmed the "backbone" role of genetic testing in the diagnosis and treatment of diseases within the domains of assisted reproduction, obstetrics, and pediatrics. Moreover, these research papers also received widespread positive feedback from both domestic and international physicians, specialists, and scientists. The distinguished delegates unanimously concurred that these were highly practically-oriented presentations that accurately and promptly reflected the current needs in the fields of assisted reproduction, obstetrics, and pediatrics in Vietnam.
Tran Thi Chi Mai, PhD. (Head of Biochemistry Department, National Children's Hospital) and Ms. Dam Anh Ngoc (Representative, GENTIS)
Participating in the 2023 Vietnam-France Obstetrics and Gynecology Conference was also one of the activities that demonstrated GENTIS' efforts to bring high-quality, safe, and effective genetic testing products to the market, further contributing positively to the responsibility for community health and advancing the practice of humane and progressive medicine.
With the comprehensive genetic testing ecosystem, GENTIS is poised to capably fulfill the requirements of medical professionals specializing in assisted reproductive technologies, obstetrics, gynecology, and pediatrics. In this regard, the company aims to contribute efforts towards the progressed development of diagnostic testing and treatment modalities within the domains of assisted reproduction, obstetrics, gynecology, and pediatrics in Vietnam.
IVF Experts Meeting is the most important and annual scientific conference in the field of assisted reproduction in Vietnam, held regularly every year, from 2005 to now. This is a reliable conference for experts, doctors, technicians, medical staff, and people working in the field of assisted reproduction to exchange, learn, improve specialized knowledge and experiences, making an important contribution to the development of Vietnam's assisted reproductive industry.
The IVF Experts Meeting conference attracted the attention of more than 500 medical doctors and experts.
This year's 18th IVF Experts Meeting conference chaired by Prof. Nguyen Thi Ngoc Phuong, M.D (Chairman of HOSREM) took place successfully, with the participation of more than 500 delegates from testing centers, IVF centers and assisted reproduction hospitals across the country. They are doctors, lab specialists, embryologists and leading experts in the field of obstetrics and gynecology across the country.
As a pioneering testing center in the field of genetic analysis, providing a full ecosystem of tests in the field of assisted reproduction, representatives of the Board of Directors of GENTIS also attended the IVF Experts Meeting 18. Leading the delegation of GENTIS was:
- Mr. Do Manh Ha (General Director of GENTIS Company)
- Pham Dinh Minh, PhD. (R&D Director of GENTIS Company)
- Nguyen Quang Vinh, M.Sc. (Director of Laboratory center of GENTIS Company)
- Mr. Hoang Dinh Khiem (Business Director of GENTIS Company)
- Ms. Dam Anh Ngoc (Marketing Manager of GENTIS Company)
- Hoang Thi Nhung, M.Sc. (R&D Specialist, GENTIS Company)
The main conference took place on August 12, 2023, including 4 sessions with a total of 20 thematic reports, research documents, and discussions,... and 7 poster reports of leading experts in the field of assisted reproduction in the country. Many questions were asked and exchanged directly and enthusiastically with leading experts in the field of assisted reproduction.
Hoang Thi Thanh Thuy, M.D., reported on the topic: "The role of the FSHR variants in assisted reproduction"
GENTIS was proud to provide data to share knowledge, technology solutions, and medical tests for experts in the field of assisted reproduction such as:
- The role of the FSHR variant in assisted reproduction - Hoang Thi Thanh Thuy, M.D. (Hanoi Medical University; National Assisted Reproductive Center)
- Sperm DNA fragmentation: from research to application - Assoc. Prof. Dr. Le Minh Tam (Hue University of Medicine and Pharmacy)
With these attractive reports, GENTIS is confident to bring many tests and clinical applications to doctors specializing in assisted reproduction. Through the topics, presentations, and scientific publications shared in the IVF Experts Meeting, Mr. Do Manh Ha (General Director of GENTIS) assessed: "This is a good opportunity for GENTIS to obtain feedback and come up with new orientations in researching, updating, and developing the latest test, medical technology and techniques for assisted reproduction in the near future".
Assoc. Prof. Dr. Le Minh Tam reported on the topic: "Sperm DNA fragmentation: from research to application"
Attending IVF Experts Meeting 18 conference was not only an opportunity for GENTIS to update the most advanced information, knowledge and technology in the field of assisted reproduction, but also an opportunity to meet, exchange, hone and learn from experts. Thereby, we can apply the most modern knowledge to improve the quality of testing at GENTIS to help infertile couples "find their beloved healthy baby".
[content_more] => [meta_title] => GENTIS participated in the annual scientific conference IVF Experts Meeting 18 [meta_description] => On August 11 – 12, 2022, GENTIS participated in the 18th Annual scientific conference IVF Experts Meeting organized by the Ho Chi Minh City Society for Reproductive Medicine (Hosrem) at the FLC Grand Hotel Ha Long - Ha Long City, Quang Ninh Province. [meta_keyword] => [thumbnail_alt] => [post_id] => 1122 [category_id] => 4 ) [6] => stdClass Object ( [id] => 1119 [id_crawler] => [category_product] => NULL [thumbnail] => 5-compressed.jpg [album] => [url_video] => [is_status] => 1 [is_featured] => 0 [is_form] => 1 [displayed_time] => 2023-08-10 [program] => 0 [number] => 1 [viewed] => 0 [type] => [type_career] => [level] => [address] => [address_career] => [expiration_time] => 0000-00-00 [created_time] => 2023-08-10 09:40:31 [updated_time] => 2024-08-15 15:23:04 [files] => [salary] => [time] => [created_by] => 63 [is_table_content] => 1 [language_code] => en [slug] => pgtest-advanced-embryo-screening-technique-for-healthy-babies [title] => PGTest - Advanced Embryo Screening Technique for Healthy Babies [description] => Having a healthy pregnancy and giving birth to healthy children may seem straightforward for most couples, but in reality, not everyone is so fortunate. With modern medical advancements, in vitro fertilization (IVF) combined with preimplantation genetic testing (PGTest) can help infertile couples select healthy embryos without any genetic disorders before transferring them to the maternal uterus. This allows couples with hereditary genetic disorders to have healthy children and eliminates the risk of genetic diseases in future generations. [content] =>1. What is Preimplantation Genetic Testing (PGTest)?
According to the Ministry of Health, the infertility rate among Vietnamese families tends to rise increasingly, accounting for about 10-12% of couples of reproductive age. Therefore, IVF has become a crucial method to help infertile families conceive and have healthy children.
For a successful IVF treatment, PGTest - pre-implantation genetic analysis is one of the decisive factors with significant benefits. Approximately 80% of successful IVF cycles are related to embryo quality, making PGTest a “lifesaver” for cases of implantation failure and recurrent miscarriages.
Pre-implantation genetic testing (PGT) is a test performed to analyze DNA from egg cells (polar bodies) or embryos (cleavage stage - morula or blastocyst stage) to identify HLA or genetic abnormalities. PGTest provides genetic health information about the embryos, helping fertility specialists select the best embryos for transfer, thus improving the chances of a successful pregnancy.
This technique increases the likelihood of conception , reduces miscarriage rates and multiple pregnancy risks, lowers the risk of single-gene disorders in the newborn, increases embryo survival rates, reduces the number of IVF cycles needed to achieve pregnancy, and saves time and costs for IVF treatments. As a result, PGTest is widely used in the field of reproductive assistance, particularly for couples undergoing IVF or intracytoplasmic sperm injection (IVF/ICSI).
2. Common Types of PGTest
Preimplantation genetic testing is divided into three main categories:
2.1. PGT- A (Preimplantation Genetic Screening for Aneuploidy)
PGT-A is a genetic test that detects chromosomal abnormalities in embryos before transferring them to the maternal uterus. It is indicated for:
- Advanced maternal age: 35 years old and above
- Multiple failed IVF attempts or recurrent miscarriages
- Family history of children born with chromosomal abnormalities
- Severe male infertility (AZF microdeletion)
2.2. PGT-SR (Preimplantation Genetic testing for structural chromosomal rearrangements)
PGT-SR is a genetic test that detects structural chromosomal abnormalities. It is indicated for couples where one partner carries structural chromosomal abnormalities such as balanced translocations, Robertsonian translocations, chromosomal deletions or duplications, or Angelman syndrome.
2.3. PGT-M (Preimplantation genetic testing for monogenic/single gene defects)
PGT-M is a preimplantation genetic testing for single-gene disorders. It is indicated for couples carrying gene mutations causing diseases like Thalassemia, spinal muscular atrophy, and cystic fibrosis, or for women carrying X-linked gene mutations (e.g., Hemophilia, Duchenne/Becker muscular dystrophy). Embryos screened by PGT-M without inherited disorders are prioritized for transfer to the maternal uterus to eliminate single-gene disorders in future generations.
3. PGTest Packages at GENTIS
Currently, GENTIS offers three PGTest kits: PGTest (PGT-A/SR), PGTest-M, and PGT Max 1 in order to help select embryos without chromosomal abnormalities and optimize embryo selection before transfer to the maternal uterus. GENTIS has also launched PGT Max 1 – a breakthrough test from PGTest with exclusive improvements unmatched by any other facility in Vietnam.
3.1. PGTest - A/SR
Analyzes DNA to detect aneuploidy in all 23 or 24 chromosome pairs and structural abnormalities (additions, deletions >5Mb)
- Method: Veriseq PGS – Illumina, USA. High resolution with over 3,000 data points; 100% sensitivity; 99.98% specificity; >1,000,000 total reads/sample, capable of detecting additions and deletions >5Mb
- Technology: Illumina Next-Generation Sequencing (NGS) – USA
- BlueFuse analytic software can identify over 130 syndromes related to chromosomal additions and deletions
- Sample: Embryo cells (day 3-5)
Note: Cannot detect balanced translocations
3.2. PGTest-M
Analyzes DNA to identify single-gene mutations in embryos related to diseases such as Thalassemia, Duchenne muscular dystrophy, hemophilia, RETT syndrome, etc.
- Method: SNP and STR analysis to detect inherited single-gene mutations from parents to embryos
- Technology: CE-Thermo, NGS Illumina – USA
- Sample: Embryo cells (day 3-5)
3.3. PGT Max-1
In addition to analyzing DNA for numerical and structural abnormalities across all 24 chromosomes and common syndromes caused by mutations >5Mb, PGT Max 1 can also detect two common microdeletions as small as 2Mb including 22q11.2 deletion (related to DiGeorge syndrome) and 1p36 deletion (related to 1p36 deletion syndrome).
- Method: Next-generation sequencing (NGS) (Illumina) and analysis of sequencing results using specialized bioinformatics software to identify aneuploidy in all 24 chromosomes and chromosomal additions/deletions
- Technology: Illumina NGS technology – USA and specialized analysis software
- Sample: Day 5 embryo biopsy
4. PGTest Procedure at GENTIS
To ensure success and collaboration with IVF centers nationwide, PGTest at GENTIS follows a strict protocol to guarantee accuracy in the results. The process requires close coordination between the assisted reproduction unit and GENTIS International Laboratory from sample collection to preservation and transportation:
- Step 1: IVF is performed, and embryos are cultured in an embryo culture medium.
- Step 2: Embryo biopsy on day 3 or day 5, collecting a small number of cells – a crucial technique requiring precision and skill from the doctor.
- Step 3: Biopsied embryo cells are sent to GENTIS International Laboratory for analysis.
- Step 4: Embryos with normal results are selected for transfer. The remaining normal embryos are frozen for future use.
5. Why Choose PGTest at GENTIS?
Currently, PGTest can be performed at some specialized hospitals or assisted reproduction centers in Vietnam, but GENTIS is one of the few pioneering units capable of performing PGTest accurately and professionally using the most advanced technology and a team of top experts. GENTIS uses a complete next-generation sequencing system, chemicals, and analysis software from Illumina - USA. Globally, 80% of facilities use Illumina systems, with numerous scientific publications on accuracy, high resolution, and detection of small-scale disorders.
Moreover, Illumina's result turnaround time is much faster than other brands like PG-Seq, Chromint (China), etc. GENTIS's use of Illumina equipment provides a significant advantage over other units in supporting doctors and couples in having healthy children.
Furthermore, GENTIS continuously strives to improve service quality, applying the most advanced testing technologies and techniques to provide customers with comprehensive solutions. This contributes to enhancing human healthcare and protection. Through PGTest, GENTIS aims to bring happiness to infertile families across the country.
The annual VUNA scientific conference is one of the important forums, attracting the attention of experts in the fields of urology, nephrology, andrology, renal transplantation, dialysis, and pediatrics. The conference is organized annually by the Vietnam Urology - Nephrology Association. The purpose of the VUNA Conference is to create conditions for experts, doctors, and nurses in the fields of urology, nephrology, andrology, renal transplantation, dialysis, and pediatrics to exchange and update knowledge, experiences to improve treatment quality at centers and hospitals across the country.
Assoc. Prof. Dr. Nguyen Quang (President of the Vietnamese Society for Sexual Medicine) and Dr. Mai Ba Tien Dung (Head of Andrology Department - Binh Dan Hospital, HCMC)
This year's 17th annual VUNA scientific conference focused on the following topics:
- New advances in the diagnosis and treatment of urological, nephrological, andrological diseases and renal transplantation
- Minimally invasive surgery in urology and nephrology (PNCL, laparoscopy, ROBO, LASER, Bipolar, ThuLEP)
The VUNA 2023 Conference attracted more than 1,000 delegates from hospitals and testing centers across the country and around the world. Within the framework of the conference, 165 reports were presented by leading domestic and international experts with in-depth professional content on nephrology, urology, andrology, renal transplantation, dialysis, and pediatrics.
Andrology Session 1 (VUNA Conference) concluded successfully with a lot of useful and practical information.
The Associate Professor said that although factors from the male account for 40-50% of infertile couples, and are on the rise, men are the least investigated and treated group in infertility. Therefore, identifying the cause of male infertility is extremely important and urgent.
Currently, in addition to the basic tests in the diagnosis and treatment of male infertility, more in-depth tests, especially the influence of genetic factors, are increasingly being interested in. Thanks to that, doctors can determine the cause of male infertility, make accurate diagnoses and personalize treatment to achieve high efficiency for each patient.
The presentation was highly appreciated for its high quality, thorough investment and received enthusiastic discussion from the delegates attending the Conference. In addition, GENTIS's Andrology tests presented by Assoc. Prof. Dr. Nguyen Quang in the presentation were of great interest to doctors and delegates because of their important role in screening, diagnosing, and treating male infertility.
Especially, sperm DNA fragmentation test, Karyotype, AZF microdeletions, Antisperm antibody (ASA), CFTR gene mutation, STDs - sexually transmitted diseases: 12 agents, Sperm aneuploidy (SAA), In-depth genetic analysis (Fertiscan).
Andrology Session 1 (VUNA Conference) concluded successfully with a lot of useful and practical information.
As a pioneer in the field of genetic analysis, GENTIS was honored to participate in this 17th VUNA Annual Scientific Conference. Hopefully, GENTIS's comprehensive Andrology testing ecosystem will be helpful for domestic and international experts and doctors in diagnosing and treating diseases related to the field of andrology, in order to improve opportunities for better care for men's health in the future.
The 17th VUNA Scientific Conference was successfully held. The event has helped doctors and experts exchange and equip themselves with specialized knowledge and professional experience in the fields of nephrology, urology, andrology, dialysis, renal transplantation, and pediatrics. Once again, GENTIS congratulates the conference on its resounding success.
GENTIS participated in the 8th Can Tho Obstetrics and Gynecology Conference
-360x194.jpg)
GENTIS is honored to be a Silver Sponsor of the 23rd Vietnam-France-Asia-Pacific Conference on Obstetrics and Gynecology
The Strategic Partnership Signing Ceremony between GENTIS and MIC Vietnam
GENTIS accompanies with the August prenatal class of General Hospital of Bac Thang Long
GENTIS is honored to be the Silver sponsor at the 2023 Vietnam-France Obstetrics and Gynecology Conference
GENTIS participated in the annual scientific conference IVF Experts Meeting 18
PGTest - Advanced Embryo Screening Technique for Healthy Babies
GENTIS attended the 17th Annual Scientific Conference of the Vietnam Urology - Nephrology Association (VUNA) 2023
Quý khách vui lòng điền thông tin bên dưới để được hỗ trợ,
tư vấn một cách tốt nhất!
Xem Socolive trực tuyến tiếng Việt
Link Bóng Đá Lu miễn phí
Link Rakhoi TV bóng đá trực tuyến
Xem tructiep https://xoilaczll.tv/
Link trực tiếp MitomTV bình luận tiếng Việt https://f8betht.baby Xem tructiep https://uniscore.com/vi NEW88 NEW88 789BET 789BET 789BETQuý khách vui lòng điền thông tin bên dưới để được hỗ trợ,
tư vấn một cách tốt nhất!
